Meta’s AI agent push puts focus on new consumer business (META:NASDAQ)

jaanalisette Meta Platforms’ (META) push into personal AI agents could give investors an early read on whether its heavy artificial intelligence spending can translate into a meaningful new consumer business. The Facebook parent has been moving its AI assistant beyond simple Source link

Science Applications Non-GAAP EPS of $3.01 beats by $0.70, revenue of $1.88B beats by $120M (SAIC:NASDAQ)

Science Applications press release (SAIC): Q2 Non-GAAP EPS of $3.01 beats by $0.70. Revenue of $1.88B (+6.2% Y/Y) beats by $120M. Revenues for the quarter increased $111 million or approximately 6% compared to the same period in the prior year primarily due Source link

Amgen’s Repatha cuts death risk by 20% in heart study (AMGN:NASDAQ)

JHVEPhoto/iStock Editorial via Getty Images Amgen (AMGN) said new findings from a pre-specified Phase 3 VESALIUS-CV trial analysis showed Repatha (evolocumab) reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke when added to statins or other LDL-C-lowering treatments. Source link

Strategy’s Michael Saylor hints at first bitcoin purchase in two months (MSTR:NASDAQ)

Joe Raedle/Getty Images News Strategy (MSTR) executive chairman Michael Saylor appeared to signal that the company has made its first Bitcoin purchase since June 22, as Bitcoin (BTC-USD) approached $79K. Saylor posted “We’re Back” on X, suggesting Strategy may have resumed Bitcoin accumulation after pausing purchases Source link